Nihon Kohden Corporation 6849
TSE · Japan · Health Technology
¥1,562.50-47.00 (-2.92%)
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Nihon Kohden (TSE:6849) was removed from the FTSE All-World Index (USD) on 19 September 2026, following an index reshuffle that can trigger portfolio changes for index-tracking funds and some institutional investors. For context, Nihon Kohden shares closed at ¥1,625.0 on the latest trading day, with a 30-day share price return of 9.28% and a 90-day share price return of 13.92%. This comes even though the year-to-date share price return is down 4.10% and the 1-year total shareholder return has...
IRVINE, Calif., August 25, 2026--Nihon Kohden, a leading provider of patient monitoring, neurology, ventilation and digital health solutions, today announced an expanded executive leadership structure designed to increase organizational capacity and strengthen alignment across the customer experience. Effective August 3, Zac Ballard was promoted to executive vice president, commercial operations, taking on leadership of sales and marketing across all four of the company’s business units — Patien
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Infant Heart Monitor Market size & share revenue was valued at approximately USD 2.83 Billion in 2025 and is expected to reach USD 3.14 Billion in 2026 and is expected to reach around USD 7.93 Billion by 2035, at a CAGR of 10.85% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are GE HealthCare, Philips, Mas
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.